Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE−/− mice

Publisher: John Wiley & Sons Inc

E-ISSN: 1755-5922|34|5|314-324

ISSN: 1755-5914

Source: CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol.34, Iss.5, 2016-10, pp. : 314-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content